NUP37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.388400E-01
Normal-vs-Stage2
9.732800E-01
Normal-vs-Stage3
3.981800E-01
Normal-vs-Stage4
9.143600E-01
Stage1-vs-Stage2
7.583000E-01
Stage1-vs-Stage3
4.925000E-01
Stage1-vs-Stage4
7.695400E-01
Stage2-vs-Stage3
2.926000E-01
Stage2-vs-Stage4
9.311800E-01
Stage3-vs-Stage4
4.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.823600E-01
Normal-vs-AfricanAmerican
5.066600E-01
Normal-vs-Asian
4.433800E-01
Caucasian-vs-AfricanAmerican
4.543000E-01
Caucasian-vs-Asian
2.953800E-01
AfricanAmerican-vs-Asian
9.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.471000E-01
Normal-vs-Female
9.301400E-01
Male-vs-Female
9.586600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.044000E-02
Normal-vs-Age(41-60Yrs)
9.536800E-01
Normal-vs-Age(61-80Yrs)
8.326000E-01
Normal-vs-Age(81-100Yrs)
6.178800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.382800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.964600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.782300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.424200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.726200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.883900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.758400E-01
Normal-vs-Daily Drinker
9.541800E-01
Normal-vs-Weekly Drinker
8.927400E-01
Normal-vs-Occasional Drinker
6.726600E-01
Normal-vs-Social Drinker
7.761200E-01
Non Drinker-vs-Daily Drinker
8.497000E-01
Non Drinker-vs-Weekly Drinker
9.882400E-01
Non Drinker-vs-Occasional Drinker
3.122400E-01
Non Drinker-vs-Social Drinker
9.181800E-01
Daily Drinker-vs-Weekly Drinker
8.752800E-01
Daily Drinker-vs-Occasional Drinker
4.592800E-01
Daily Drinker-vs-Social Drinker
7.886000E-01
Weekly Drinker-vs-Occasional Drinker
4.148000E-01
Weekly Drinker-vs-Social Drinker
9.458600E-01
Occasional Drinker-vs-Social Drinker
2.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.128000E-01
Normal-vs-Grade 2
9.004600E-01
Normal-vs-Grade 3
5.434800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.876750E-03
Grade 1-vs-Grade 3
4.179200E-04
Grade 1-vs-Grade 4
9.128000E-01
Grade 2-vs-Grade 3
1.709030E-01
Grade 2-vs-Grade 4
9.004600E-01
Grade 3-vs-Grade 4
5.434800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.910000E-01
Normal-vs-NonDiabetic
8.314200E-01
Diabetic-vs-NonDiabetic
8.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.961400E-01
Normal-vs-NoPancreatitis
8.981600E-01
Pancreatitis-vs-NoPancreatitis
6.861200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.308800E-01
Normal-vs-N1
9.579800E-01
N0-vs-N1
2.045000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.053400E-01
Normal-vs-TP53-NonMutant
8.443200E-01
TP53-Mutant-vs-TP53-NonMutant
3.950400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
